TSLS icon

Direxion Daily TSLA Bear 1X ETF

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 33.3%
Negative

Positive
ETF Trends
yesterday
Derivative-Based Strategies Take Center Stage at Asset Allocation Summit
The sheer complexity of exchange-traded funds (ETFs) using derivative-based strategies could have investors turning the other away. Instead, investors have been running towards them.
Derivative-Based Strategies Take Center Stage at Asset Allocation Summit
Positive
ETF Trends
2 days ago
Asset Allocation Summit: Opportunities in Direxion's Leveraged-Inverse Suite
In the high-velocity environment of equities trading, a heavy dose of volatility equates to plenty of opportunities. The capital markets saw exactly that in the first quarter of 2026, which saw strong demand for Direxion Investments' leveraged-inverse ETF product suite.
Asset Allocation Summit: Opportunities in Direxion's Leveraged-Inverse Suite
Positive
ETF Trends
7 days ago
Put the Tesla Pedal to the Metal With These ETFs
First-quarter earnings season is accelerating and the automotive euphemism is a good segue into noting that Tesla, Inc. (TSLA) reports results for the first three months of 2026 on Wednesday, April 2022. Tesla said it will release the report after U.S. markets close.
Put the Tesla Pedal to the Metal With These ETFs
Neutral
GlobeNewsWire
1 month ago
Direxion Announces Date Change for Reverse Split of MUD & TSLS
New York, New York, USA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Direxion, a leading provider of ETFs for tactical traders, has announced date changes for the reverse split of the issued and outstanding shares of the Direxion Daily MU Bear 1X Shares and Direxion Daily TSLA Bear 1X Shares, (the “Funds”). The total market value of the shares outstanding will not be affected as a result of this split, except with respect to the redemption of fractional shares, as outlined below.
Direxion Announces Date Change for Reverse Split of MUD & TSLS
Positive
ETF Trends
2 months ago
7 Potential Trades Following Supreme Court's Tariffs Ruling
Tariffs continue to be the wild card swaying markets, but traders can agree that it clears a pathway for potential ideas. The Supreme Court's landmark ruling that struck down presidential tariff authority could create a high-velocity trading environment—a perfect setup for Direxion's suite of leveraged-inverse ETFs.
7 Potential Trades Following Supreme Court's Tariffs Ruling
Neutral
ETF Trends
2 months ago
Did This Trio Confirm the Mag 7's Magnificence After Earnings?
Meta, Microsoft, and Tesla reported earnings after the bell, with investors looking for indicators that the Magnificent Seven is still magnificent in the early going of 2026. The result—so far so good—but was it magnificent?
Did This Trio Confirm the Mag 7's Magnificence After Earnings?
Neutral
ETF Trends
5 months ago
A Tale of 2 Tesla ETFs
Shares of Tesla (TSLA) fell 1.30% two weeks ago, after the EV giant reported mixed third-quarter results. Elon Musk's company said overall revenue rose 12%.
A Tale of 2 Tesla ETFs
Positive
ETF Trends
9 months ago
Tesla's Robotaxi Signals Readiness to Compete With Mag 7 Peers
The primary theme turbocharging the Magnificent Seven is the inclusion of artificial intelligence (AI). Tesla's launch of its AI robotaxi is signaling to its Mag Seven peers that the company is ready to compete with the big boys.
Tesla's Robotaxi Signals Readiness to Compete With Mag 7 Peers
Positive
ETF Trends
9 months ago
Can Meta's Latest Acquisition Make It a Prime Time AI Player?
If you're going to be part of the Magnificent Seven, you better do something that's, well
Can Meta's Latest Acquisition Make It a Prime Time AI Player?
Positive
ETF Trends
10 months ago
7 Stocks Looking Magnificent Again; Caution Warranted
As seasoned investors already know, the 24-hour news cycle can change markets quickly and swiftly. After weathering the tariff tantrum storm, downtrodden Magnificent Seven stocks are starting to look magnificent again thanks to U.S.-China trade deal news, but caution is always warranted.
7 Stocks Looking Magnificent Again; Caution Warranted